MedPath

SINPHAR PHARMACEUTICAL CO., LTD.

SINPHAR PHARMACEUTICAL CO., LTD. logo
🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:4

Trial Phases

2 Phases

Phase 2:4
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (80.0%)
Phase 4
1 (20.0%)

Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

Phase 4
Completed
Conditions
Stage-Ⅱ Colorectal Cancer
Interventions
Drug: Orectalip
First Posted Date
2014-11-06
Last Posted Date
2014-11-06
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
20
Registration Number
NCT02284529
Locations
🇨🇳

Taichung Veterans General Hospital, Taichung, Taiwan

Phase II Study of STA-2 in Patients With Chronic Stable Angina

Phase 2
Completed
Conditions
Chronic Stable Angina
Interventions
Drug: Placebo
First Posted Date
2011-12-02
Last Posted Date
2011-12-06
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
79
Registration Number
NCT01484912
Locations
🇨🇳

Chi Mei Medical Center, Tainan, Taiwan

🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)

Phase 2
Completed
Conditions
Vascular Dementia
Interventions
Drug: Ergoloid Mesylates tablet
First Posted Date
2011-11-21
Last Posted Date
2011-11-21
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
240
Registration Number
NCT01475578
Locations
🇨🇳

Affiliated Hospital of Chengdu University of Traditional Chinese Medicines, China, Chengdu, China

🇨🇳

Fujian Academy of Traditional Chinese Medicine, Fujian, China

🇨🇳

Hospital (Traditional Chinese Medicine) Affiliated to Luzhou Medical College, Luzhou, China

and more 2 locations

Study of STA-1 as an Add-on Treatment to Donepezil

Phase 2
Conditions
Alzheimer Disease
Interventions
Drug: Donepezil,
Drug: placebo
First Posted Date
2010-12-07
Last Posted Date
2014-08-20
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
136
Registration Number
NCT01255046
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

Phase IIb Study of STA-2 in Patients With Chronic Stable Angina

Phase 2
Completed
Conditions
Chronic Stable Angina
Interventions
Drug: green tea polyphenols (STA-2)
First Posted Date
2010-11-11
Last Posted Date
2014-08-27
Lead Sponsor
Sinphar Pharmaceutical Co., Ltd
Target Recruit Count
186
Registration Number
NCT01239511
Locations
🇨🇳

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

🇨🇳

Chi Mei Medical Center, Tainan, Taiwan

🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.